Advertisement

Engaging hematopoietic cell transplantation patients and caregivers in the design of print and mobile application individualized survivorship care plan tools

  • Jaime M. PreusslerEmail author
  • Ellen M. Denzen
  • Navneet S. Majhail
  • K. Scott Baker
  • Meggan McCann
  • Linda J. Burns
  • Jean Yi
  • Karen L. Syrjala
Original Article
  • 20 Downloads

Abstract

Purpose

INSPIRE (INteractive Survivorship Program with Information and REsources) is an online health program that includes a mobile app, website, health action plan, and individualized survivorship care plans for adult hematopoietic cell transplant (HCT) survivors. The INSPIRE program integrates two previously effective randomized control trials that tested an internet-based program and patient-centered survivorship care plans for HCT survivors.

Methods

Three focus groups were conducted with a total of 22 participants (20 patients, 2 caregivers/patient advocates) to explore patient and caregiver preferences and to optimize the patient-centered emphasis of INSPIRE. Adult (age > 18 years at the time of study entry) HCT recipients had to be at least 1-year post-HCT to participate; caregivers/patient advocates were also eligible. Participants had to be able to communicate in English, could have any diagnosis, transplant type, or donor source, and could have had multiple transplants.

Results

All patient participants received an allogeneic HCT; average time since HCT was 8 years (range 2–22 years). The majority of participants were female (77.3%). Overall, the tools were well received by participants in this study, particularly the personalized features of all the tools. Major themes included interest in having the ability to tailor features to individual needs, and an interest in tracking information over time.

Discussion

Engaging patients and caregivers is invaluable to optimize tools designed to improve HCT survivorship care. Print, online, and mobile-based tools, tailored to individual patients’ treatment history and requisite follow-up care, can provide otherwise unavailable expertise and guidelines for care.

Keywords

Survivorship care plan Hematopoietic cell transplantation Patient preferences Patient-centered Mobile app 

Notes

Acknowledgments

This research was supported by an NIH grant (R01-CA215134) to Karen L. Syrjala, K. Scott Baker, and Navneet S. Majhail. The study investigators thank the patients and caregivers who participated in the focus groups and provided feedback on the Survivorship Care Plan, My Health Action Plan, and mobile app. The study investigators also thank Katie Schoppner, MSW, LICSW, from NMDP/Be The Match, who served as a moderator for the focus groups.

Funding information

This research was supported by a grant from the National Cancer Institute, R01 CA215134.

The authors have full control of all primary data and agree to allow the journal to review it if requested.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Disclosures

CIBMTR® (Center for International Blood and Marrow Transplant Research®) is a research collaboration between the National Marrow Donor Program®/Be The Match® and Medical College of Wisconsin. The CIBMTR is supported by Public Health Service Grant/Cooperative Agreement U24-CA76518 from the National Cancer Institute (NCI), the National Heart, Lung and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases (NIAID); a Grant/Cooperative Agreement 5U01HL069294 from NHLBI and NCI; a contract HHSH234200637015C with Health Resources and Services Administration (HRSA/DHHS); two Grants N00014-06-1-0704 and N00014-08-1-0058 from the Office of Naval Research; and grants from AABB; Allos, Inc.; Amgen, Inc. Anonymous donation to the Medical College of Wisconsin; Astellas Pharma US, Inc.; Be the Match Foundation; Biogen IDEC; BioMarin Pharmaceutical, Inc.; Biovitrum AB; BloodCenter of Wisconsin; Blue Cross and Blue Shield Association; Bone Marrow Foundation; Buchanan Family Foundation; CaridianBCT; Celgene Corporation; CellGenix, GmbH; Children’s Leukemia Research Association; ClinImmune Labs; CTI Clinical Trial and Consulting Services; Eisai, Inc.; Genentech, Inc.; Genzyme Corporation; Histogenetics, Inc.; HKS Medical Information Systems; Hospira, Inc.; Kirin Brewery Co., Ltd.; The Leukemia & Lymphoma Society; Merck & Company; The Medical College of Wisconsin; Millennium Pharmaceuticals, Inc.; Miller Pharmacal Group; Milliman USA, Inc.; Miltenyi Biotec, Inc.; National Marrow Donor Program; Nature Publishing Group; Novartis Oncology; Oncology Nursing Society; Osiris Therapeutics, Inc.; Otsuka America Pharmaceutical, Inc.; Pall Life Sciences; Pfizer Inc; Schering Corporation; Sigma-Tau Pharmaceuticals; Soligenix, Inc.; StemCyte, Inc.; StemSoft Software, Inc.; Sysmex America, Inc.; THERAKOS, Inc.; Vidacare Corporation; ViraCor Laboratories; ViroPharma, Inc.; and Wellpoint, Inc. The views expressed in this article do not reflect the official policy or position of the National Institutes of Health, the Department of the Navy, the Department of Defense, or any other agency of the US Government.

The Health Services Research program is supported in part by Health Resources and Services Administration Contract No. HHSH234200637018C. The views expressed in this article do not reflect the official policy or position of the Health Resources and Services Administration or the National Marrow Donor Program/Be The Match®.

Supplementary material

520_2019_5114_MOESM1_ESM.docx (20 kb)
ESM 1 (DOCX 84 kb)
520_2019_5114_MOESM2_ESM.docx (84 kb)
ESM 2 (DOCX 20 kb)

References

  1. 1.
    Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, van Lint M, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research (CIBMTR), American Society for Blood and Marrow Transplantation (ASBMT), European Group for Blood and Marrow Transplantation (EBMT), Asia-Pacific Blood and Marrow Transplantation Group (APBMT), Bone Marrow Transplant Society of Australia and New Zealand (BMTSANZ), East Mediterranean Blood and Marrow Transplantation Group (EMBMT), Sociedade Brasileira de Transplante de Medula Ossea (SBTMO) (2012) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 18(3):348–371.  https://doi.org/10.1016/j.bbmt.2011.12.519 CrossRefGoogle Scholar
  2. 2.
    Mosher CE, DuHamel KN, Rini C, Corner G, Lam J, Redd WH (2011) Quality of life concerns and depression among hematopoietic stem cell transplant survivors. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 19(9):1357–1365.  https://doi.org/10.1007/s00520-010-0958-y CrossRefGoogle Scholar
  3. 3.
    Rusiewicz A, DuHamel KN, Burkhalter J, Ostroff J, Winkel G, Scigliano E, Papadopoulos E, Moskowitz C, Redd W (2008) Psychological distress in long-term survivors of hematopoietic stem cell transplantation. Psychooncology. 17(4):329–337.  https://doi.org/10.1002/pon.1221 CrossRefPubMedGoogle Scholar
  4. 4.
    Hefner J, Kapp M, Drebinger K, Dannenmann A, Einsele H, Grigoleit GU, Faller H, Csef H, Mielke S (2014) High prevalence of distress in patients after allogeneic hematopoietic SCT: fear of progression is associated with a younger age. Bone Marrow Transplant 49(4):581–584.  https://doi.org/10.1038/bmt.2013.228 CrossRefPubMedGoogle Scholar
  5. 5.
    Syrjala KL, Martin PJ, Lee SJ (2012) Delivering care to long-term adult survivors of hematopoietic cell transplantation. J Clin Oncol Off J Am Soc Clin Oncol 30(30):3746–3751.  https://doi.org/10.1200/JCO.2012.42.3038 CrossRefGoogle Scholar
  6. 6.
    Bevans M, El-Jawahri A, Tierney DK et al (2017) National Institutes of Health Hematopoietic Cell Transplantation late effects initiative: The Patient-Centered Outcomes Working Group Report. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 23(4):538–551.  https://doi.org/10.1016/j.bbmt.2016.09.011 CrossRefGoogle Scholar
  7. 7.
    Blanch-Hartigan D, Blake KD, Viswanath K (2014) Cancer survivors’ use of numerous information sources for cancer-related information: does more matter? J Cancer Educ Off J Am Assoc Cancer Educ 29(3):488–496.  https://doi.org/10.1007/s13187-014-0642-x CrossRefGoogle Scholar
  8. 8.
    Finney Rutten LJ, Agunwamba AA, Wilson P et al (2016) Cancer-related information seeking among cancer survivors: trends over a decade (2003-2013). J Cancer Educ Off J Am Assoc Cancer Educ 31(2):348–357.  https://doi.org/10.1007/s13187-015-0802-7 CrossRefGoogle Scholar
  9. 9.
    Shea-Budgell MA, Kostaras X, Myhill KP, Hagen NA (2014) Information needs and sources of information for patients during cancer follow-up. Curr Oncol Tor Ont 21(4):165–173.  https://doi.org/10.3747/co.21.1932 CrossRefGoogle Scholar
  10. 10.
    Jansen F, van Uden-Kraan CF, van Zwieten V, Witte BI, Verdonck-de Leeuw IM (2015) Cancer survivors’ perceived need for supportive care and their attitude towards self-management and eHealth. Support Care Cancer Off J Multinatl Assoc Support Care Cancer 23(6):1679–1688.  https://doi.org/10.1007/s00520-014-2514-7 CrossRefGoogle Scholar
  11. 11.
    Cancer Program Standards (2016 Edition). American College of Surgeons. https://www.facs.org/quality-programs/cancer/coc/standards. Accessed November 21, 2017.
  12. 12.
    Hewitt M, Greenfield S, Stovall E (2005) From Cancer Patient to Cancer Survivor: Lost in Transition. The National Academies Press, WashingtonGoogle Scholar
  13. 13.
    Majhail NS, Murphy E, Laud P et al (2018) Randomized controlled trial of individualized treatment summary and survivorship care plans for hematopoietic cell transplantation survivors. Haematologica.  https://doi.org/10.3324/haematol.2018.203919 CrossRefGoogle Scholar
  14. 14.
    Denzen EM, Preussler JM, Murphy EA et al (2018) Tailoring a survivorship care plan: patient and provider preferences for recipients of hematopoietic cell transplantation. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant.  https://doi.org/10.1016/j.bbmt.2018.10.005 CrossRefGoogle Scholar
  15. 15.
    Syrjala KL, Yi JC, Artherholt SB, Romano JM, Crouch ML, Fiscalini AS, Hegel MT, Flowers MED, Martin PJ, Leisenring WM (2018) An online randomized controlled trial, with or without problem-solving treatment, for long-term cancer survivors after hematopoietic cell transplantation. J Cancer Surviv Res Pract 12(4):560–570.  https://doi.org/10.1007/s11764-018-0693-9 CrossRefGoogle Scholar
  16. 16.
    Syrjala KL, Crouch M-L, Leisenring WM et al (2018) Engagement with INSPIRE, an Online Program for Hematopoietic Cell Transplantation Survivors. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 24(8):1692–1698.  https://doi.org/10.1016/j.bbmt.2018.05.004 CrossRefGoogle Scholar
  17. 17.
    Be The Match. Living Now Enewsletter- subscribe. https://cloud.bethematch-mail.org/LivingNow. Accessed September 4, 2019.
  18. 18.
    Be The Match. Be The Match Blog; previous editions of Living Now enewsletter. https://bethematch.org/blog/. Accessed August 28, 2019.
  19. 19.
    Be The Match - Patients Connect. https://www.facebook.com/BeTheMatchPatient/. Accessed August 28, 2019.
  20. 20.
    Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, van Lint M, Wingard JR, Tichelli A, Center for International Blood and Marrow Transplant Research, American Society for Blood and Marrow Transplantation, European Group for Blood and Marrow Transplantation, Asia-Pacific Blood and Marrow Transplantation Group, Bone Marrow Transplant Society of Australia and New Zealand, East Mediterranean Blood and Marrow Transplantation Group, Sociedade Brasileira de Transplante de Medula Ossea (2012) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Bone Marrow Transplant 47(3):337–341.  https://doi.org/10.1038/bmt.2012.5 CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Majhail NS, Rizzo JD, Lee SJ, Aljurf M, Atsuta Y, Bonfim C, Burns LJ, Chaudhri N, Davies S, Okamoto S, Seber A, Socie G, Szer J, Lint MT, Wingard JR, Tichelli A (2012) Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation. Rev Bras Hematol E Hemoter 34(2):109–133.  https://doi.org/10.5581/1516-8484.20120032 CrossRefGoogle Scholar
  22. 22.
    Krueger RA, Casey MA (2000) Focus Groups: A Practical Guide for Applied Research, 3rd edn. SAGE Publications, Inc, Thousand OaksGoogle Scholar
  23. 23.
    Nvivo - QSR International. How should the value of Kappa be interpreted? NVivo 10 for Windows Help. http://help-nv10.qsrinternational.com/desktop/procedures/run_a_coding_comparison_query.htm. Accessed September 16, 2014.
  24. 24.
    McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Medica 22(3):276–282CrossRefGoogle Scholar
  25. 25.
    MacQueen KM, McLellan E, Kay K, Milstein B (1998) Codebook Development for Team-Based Qualitative Analysis. Field Methods 10(2):31–36.  https://doi.org/10.1177/1525822X980100020301 CrossRefGoogle Scholar
  26. 26.
    Featherall J, Lapin B, Chaitoff A, Havele SA, Thompson N, Katzan I (2018) Characterization of patient interest in provider-based consumer health information technology: survey study. J Med Internet Res 20(4):e128.  https://doi.org/10.2196/jmir.7766 CrossRefPubMedPubMedCentralGoogle Scholar
  27. 27.
    Hunt JS, Gibson RF, Whittington J, Powell K, Wozney B, Knudson S (2015) Guide for Developing an information technology investment road map for population health management. Popul Health Manag 18(3):159–171.  https://doi.org/10.1089/pop.2014.0092 CrossRefPubMedGoogle Scholar
  28. 28.
    Chen Z, Koh PW, Ritter PL, Lorig K, Bantum EO, Saria S (2015) Dissecting an online intervention for cancer survivors: four exploratory analyses of internet engagement and its effects on health status and health behaviors. Health Educ Behav Off Publ Soc Public Health Educ 42(1):32–45.  https://doi.org/10.1177/1090198114550822 CrossRefGoogle Scholar
  29. 29.
    Brennan ME, Gormally JF, Butow P, Boyle FM, Spillane AJ (2014) Survivorship care plans in cancer: a systematic review of care plan outcomes. Br J Cancer 111(10):1899–1908.  https://doi.org/10.1038/bjc.2014.505 CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Jacobsen PB, DeRosa AP, Henderson TO et al (2018) Systematic review of the impact of cancer survivorship care plans on health outcomes and health care delivery. J Clin Oncol Off J Am Soc Clin Oncol 36(20):2088–2100.  https://doi.org/10.1200/JCO.2018.77.7482 CrossRefGoogle Scholar
  31. 31.
    Boekhout AH, Maunsell E, Pond GR et al (2015) A survivorship care plan for breast cancer survivors: extended results of a randomized clinical trial. J Cancer Surviv Res Pract 9(4):683–691.  https://doi.org/10.1007/s11764-015-0443-1 CrossRefGoogle Scholar
  32. 32.
    Faul LA, Luta G, Sheppard V, Isaacs C, Cohen HJ, Muss HB, Yung R, Clapp JD, Winer E, Hudis C, Tallarico M, Wang J, Barry WT, Mandelblatt JS (2014) Associations among survivorship care plans, experiences of survivorship care, and functioning in older breast cancer survivors: CALGB/Alliance 369901. J Cancer Surviv Res Pract 8(4):627–637.  https://doi.org/10.1007/s11764-014-0371-5 CrossRefGoogle Scholar
  33. 33.
    Grunfeld E, Julian JA, Pond G, Maunsell E, Coyle D, Folkes A, Joy AA, Provencher L, Rayson D, Rheaume DE, Porter GA, Paszat LF, Pritchard KI, Robidoux A, Smith S, Sussman J, Dent S, Sisler J, Wiernikowski J, Levine MN (2011) Evaluating survivorship care plans: results of a randomized, clinical trial of patients with breast cancer. J Clin Oncol Off J Am Soc Clin Oncol 29(36):4755–4762.  https://doi.org/10.1200/JCO.2011.36.8373 CrossRefGoogle Scholar
  34. 34.
    Hebdon M, Abrahamson K, McComb S, Sands L (2014) Transitioning patients to survivorship care: a systematic review. Oncol Nurs Forum 41(6):615–625.  https://doi.org/10.1188/14.ONF.615-625 CrossRefPubMedGoogle Scholar
  35. 35.
    Hill-Kayser CE, Vachani CC, Hampshire MK, Di Lullo G, Jacobs LA, Metz JM (2013) Impact of internet-based cancer survivorship care plans on health care and lifestyle behaviors. Cancer. 119(21):3854–3860.  https://doi.org/10.1002/cncr.28286 CrossRefPubMedGoogle Scholar
  36. 36.
    Keesing S, McNamara B, Rosenwax L (2015) Cancer survivors’ experiences of using survivorship care plans: a systematic review of qualitative studies. J Cancer Surviv Res Pract 9(2):260–268.  https://doi.org/10.1007/s11764-014-0407-x CrossRefGoogle Scholar
  37. 37.
    Klemanski DL, Browning KK, Kue J (2016) Survivorship care plan preferences of cancer survivors and health care providers: a systematic review and quality appraisal of the evidence. J Cancer Surviv Res Pract 10(1):71–86.  https://doi.org/10.1007/s11764-015-0452-0 CrossRefGoogle Scholar
  38. 38.
    Mayer DK, Birken SA, Check DK, Chen RC (2015) Summing it up: an integrative review of studies of cancer survivorship care plans (2006-2013). Cancer. 121(7):978–996.  https://doi.org/10.1002/cncr.28884 CrossRefPubMedGoogle Scholar
  39. 39.
    McCabe MS, Partridge AH, Grunfeld E, Hudson MM (2013) Risk-based health care, the cancer survivor, the oncologist, and the primary care physician. Semin Oncol 40(6):804–812.  https://doi.org/10.1053/j.seminoncol.2013.09.004 CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Nicolaije KAH, Ezendam NPM, Vos MC, Pijnenborg JM, Boll D, Boss EA, Hermans RH, Engelhart KC, Haartsen JE, Pijlman BM, van Loon-Baelemans I, Mertens HJ, Nolting WE, van Beek J, Roukema JA, Zijlstra WP, Kruitwagen RF, van de Poll-Franse L (2015) Impact of an automatically generated cancer survivorship care plan on patient-reported outcomes in routine clinical practice: longitudinal outcomes of a pragmatic, cluster randomized trial. J Clin Oncol Off J Am Soc Clin Oncol 33(31):3550–3559.  https://doi.org/10.1200/JCO.2014.60.3399 CrossRefGoogle Scholar
  41. 41.
    Palmer SC, Stricker CT, Panzer SL, Arvey SA, Baker KS, Casillas J, Ganz PA, McCabe M, Nekhlyudov L, Overholser L, Partridge AH, Risendal B, Rosenstein DL, Syrjala KL, Jacobs LA (2015) Outcomes and satisfaction after delivery of a breast cancer survivorship care plan: results of a multicenter trial. J Oncol Pract 11(2):e222–e229.  https://doi.org/10.1200/JOP.2014.001404 CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Sprague BL, Dittus KL, Pace CM, Dulko D, Pollack LA, Hawkins NA, Geller BM (2013) Patient satisfaction with breast and colorectal cancer survivorship care plans. Clin J Oncol Nurs 17(3):266–272.  https://doi.org/10.1188/13.CJON.17-03AP CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Rosenberg CA, Flanagan C, Brockstein B, Obel JC, Dragon LH, Merkel DE, Wade EL, Law TM, Khandekar JD, Hensing TA (2016) Promotion of self-management for post treatment cancer survivors: evaluation of a risk-adapted visit. J Cancer Surviv Res Pract 10(1):206–219.  https://doi.org/10.1007/s11764-015-0467-6 CrossRefGoogle Scholar
  44. 44.
    Boyajian RN, Grose A, Grenon N et al (2014) Desired elements and timing of cancer survivorship care: one approach may not fit all. J Oncol Pract 10(5):e293–e298.  https://doi.org/10.1200/JOP.2013.001192 CrossRefPubMedGoogle Scholar
  45. 45.
    O’Malley DM, Hudson SV, Ohman-Strickland PA et al (2016) Follow-up care education and information: identifying cancer survivors in need of more guidance. J Cancer Educ Off J Am Assoc Cancer Educ 31(1):63–69.  https://doi.org/10.1007/s13187-014-0775-y CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Jaime M. Preussler
    • 1
    • 2
    Email author
  • Ellen M. Denzen
    • 1
    • 2
  • Navneet S. Majhail
    • 3
  • K. Scott Baker
    • 4
  • Meggan McCann
    • 1
  • Linda J. Burns
    • 1
    • 2
  • Jean Yi
    • 4
  • Karen L. Syrjala
    • 4
  1. 1.National Marrow Donor Program/Be The MatchMinneapolisUSA
  2. 2.Center for International Blood and Marrow Transplant ResearchMinneapolisUSA
  3. 3.Blood & Marrow Transplant Program, Cleveland ClinicClevelandUSA
  4. 4.Fred Hutchinson Cancer Research CenterSeattleUSA

Personalised recommendations